Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support ...
Launched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced a major milestone Sunday — raising $175 million in a Series B funding round to support its ...
Which companies attracted the big funding rounds, and how much did they raise? Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, raised a $175 million Series B ...
Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, raised over $175 million in January. Seattle-based Umoja Biopharma raised $100 million the same week Tune and ...
Advancements with Ted Danson is scheduled to broadcast on Saturday, February 22, 2025, at 8:00 pm ET. Check your local ...
She has held research leadership roles at organizations including Juno Therapeutics, Celgene, and Lyell Immunopharma and is currently the head of research at Tune Therapeutics. She brings strong ...